Stefan Pabst

3.1k total citations
60 papers, 1.9k citations indexed

About

Stefan Pabst is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Stefan Pabst has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 31 papers in Physiology and 19 papers in Molecular Biology. Recurrent topics in Stefan Pabst's work include Sarcoidosis and Beryllium Toxicity Research (20 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Pulmonary Hypertension Research and Treatments (10 papers). Stefan Pabst is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (20 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers) and Pulmonary Hypertension Research and Treatments (10 papers). Stefan Pabst collaborates with scholars based in Germany, United States and Austria. Stefan Pabst's co-authors include Reinhard Jahn, Dirk Fasshauer, Martin Margittai, Wolfram Antonin, Christian Grohé, Dirk Skowasch, Georg Nickenig, Ralf Langen, Christoph Hammerstingl and Josep Rizo and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Stefan Pabst

58 papers receiving 1.9k citations

Peers

Stefan Pabst
Joseph E. Aslan United States
Thai Tran Singapore
Robin Kunkel United States
Aleksandar Ívetic United Kingdom
Patrice M. Becker United States
Joseph E. Aslan United States
Stefan Pabst
Citations per year, relative to Stefan Pabst Stefan Pabst (= 1×) peers Joseph E. Aslan

Countries citing papers authored by Stefan Pabst

Since Specialization
Citations

This map shows the geographic impact of Stefan Pabst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Pabst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Pabst more than expected).

Fields of papers citing papers by Stefan Pabst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Pabst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Pabst. The network helps show where Stefan Pabst may publish in the future.

Co-authorship network of co-authors of Stefan Pabst

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Pabst. A scholar is included among the top collaborators of Stefan Pabst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Pabst. Stefan Pabst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pabst, Stefan, Helle D. Ulrich, Niels H. Gehring, et al.. (2019). Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain. Nature Communications. 10(1). 3678–3678. 56 indexed citations
2.
Kovács, Gábor, Daniel Dumitrescu, Sebastian Greiner, et al.. (2018). Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018. International Journal of Cardiology. 272. 11–19. 57 indexed citations
3.
Jaehrling, Jan, et al.. (2015). Solution Equilibrium Titration for High-Throughput Affinity Estimation of Unpurified Antibodies and Antibody Fragments. SLAS DISCOVERY. 20(10). 1256–1267. 9 indexed citations
4.
Hammerstingl, Christoph, Robert Schueler, Martin H. J. Wiesen, et al.. (2013). Impact of Untreated Obstructive Sleep Apnea on Left and Right Ventricular Myocardial Function and Effects of CPAP Therapy. PLoS ONE. 8(10). e76352–e76352. 36 indexed citations
5.
Ostendorp, Ralf, et al.. (2013). An automated immunoassay for early specificity profiling of antibodies. mAbs. 5(2). 279–287. 10 indexed citations
6.
Pabst, Stefan, Christoph Hammerstingl, Jens Kreuz, et al.. (2012). Pulmonary Arterial Hypertension in Patients with Sarcoidosis: The Pulsar Single Center Experience. Advances in experimental medicine and biology. 755. 299–305. 17 indexed citations
7.
Hammerstingl, Christoph, Robert Schueler, Diana Momčilović, et al.. (2012). Diagnostic Value of Echocardiography in the Diagnosis of Pulmonary Hypertension. PLoS ONE. 7(6). e38519–e38519. 44 indexed citations
8.
Pabst, Stefan, et al.. (2012). Toll-Like Receptor-9 Polymorphisms in Sarcoidosis and Chronic Obstructive Pulmonary Disease. Advances in experimental medicine and biology. 756. 239–245. 27 indexed citations
9.
Pabst, Stefan, Christoph Hammerstingl, Thomas Gerhardt, et al.. (2012). Pulmonary Hypertension in Patients with Chronic Kidney Disease on Dialysis and without Dialysis: Results of the PEPPER-Study. PLoS ONE. 7(4). e35310–e35310. 101 indexed citations
10.
Schuette, Wolfgang, S. Nagel, Ludwig Fischer von Weikersthal, et al.. (2011). Randomized Phase III Trial of Docetaxel Plus Carboplatin with or without Levofloxacin Prophylaxis in Elderly Patients with Advanced Non-small Cell Lung Cancer: The APRONTA Trial. Journal of Thoracic Oncology. 6(12). 2090–2096. 10 indexed citations
11.
Skowasch, Dirk, et al.. (2011). Diabetes insipidus bei Neurosarkoidose. Pneumologie. 65(8). 496–497. 2 indexed citations
12.
Grünig, Ekkehard, Michael Bell, Martin Claussen, et al.. (2011). Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with Updated Commentary of the Cologne Consensus Conference 2011. International Journal of Cardiology. 154. S3–S12. 58 indexed citations
13.
Pabst, Stefan, Sara Stier, Georg Nickenig, et al.. (2010). Transforming growth factor-β gene polymorphisms in different phenotypes of sarcoidosis. European Respiratory Journal. 38(1). 169–175. 30 indexed citations
14.
Hoyer, Friedrich Felix, Lars Lickfett, E. L. Mittmann-Braun, et al.. (2010). High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. Journal of Interventional Cardiac Electrophysiology. 29(1). 37–41. 50 indexed citations
15.
Pabst, Stefan, Christoph Hammerstingl, Georg Nickenig, & Dirk Skowasch. (2010). Praktisches Management der pulmonal arteriellen Hypertonie. Therapie nach aktuellen Leitlinien. Pharmazie in unserer Zeit. 39(6). 448–452.
16.
Skowasch, Dirk, Izabela Tuleta, Martin Steinmetz, et al.. (2009). Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions.. PubMed. 18(4). 411–7. 13 indexed citations
17.
Pabst, Stefan, Adrian Gillissen, Martina Lennarz, et al.. (2009). ADAM33 gene polymorphisms in chronic obstructive pulmonary disease. European journal of medical research. 14(S4). 182–6. 10 indexed citations
18.
Pabst, Stefan, Vedat Tiyerili, & Christian Grohé. (2008). Apparent response to anti-IgE therapy in two patients with refractory "forme fruste" of Churg-Strauss syndrome. Thorax. 63(8). 747–748. 32 indexed citations
19.
Margittai, Martin, Dirk Fasshauer, Stefan Pabst, Reinhard Jahn, & Ralf Langen. (2001). Homo- and Heterooligomeric SNARE Complexes Studied by Site-directed Spin Labeling. Journal of Biological Chemistry. 276(16). 13169–13177. 109 indexed citations
20.
Pabst, Stefan, Wolfram Antonin, Thomas C. Südhof, et al.. (2000). Selective Interaction of Complexin with the Neuronal SNARE Complex. Journal of Biological Chemistry. 275(26). 19808–19818. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026